Cardium Therapeutics Inc (NYSE MKT LLC:CXM)
| 0.0877 Data as of May 17 |  -0.0034 / -3.73%Today’s Change | 0.06 Today|||52-Week Range 0.28 | -53.84% Year-to-Date |
Latest CXM News | Press Releases
No recent news for Cardium Therapeutics Inc.
Today’s Trading
| Previous close | 0.09 |
| Today’s open | 0.09 |
| Day’s range | 0.09 - 0.10 |
| Volume | 211,298 |
| Average volume (3 months) | 510,551 |
| Market cap | $11.4M |
| Dividend yield | -- |
Data as of 3:50pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +12.13% |
| Earnings growth (this year) | +28.57% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 28.66 |
| Price/Book | 1.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OXBTOxygen Biotherapeuti... | +0.12 | +2.80% |
| CBMXCombiMatrix Corp | +0.01 | +0.30% |
| ICCCImmuCell Corp | -0.19 | -5.22% |
| --Premier Biomedical I... | 0.00 | 0.00% |
Data as of 3:59pm ET, 05/17/2013
Financials
| Last reporting date | May 13, 2013 |
| EPS forecast (this quarter) | -$0.01 |
| Annual revenue (last year) | $785.3K |
| Annual profit (last year) | -$8.3M |
| Net profit margin | -1,059.86% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, President, CEO & Treasurer Christopher J. Reinhard, MBA |
Chief Financial Officer Dennis M. Mulroy, CPA |
Corporate headquarters San Diego, California |
Forecasts
